Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Blood|April 1, 1984
Inhibition of platelet function by cis-unsaturated fatty acidsD E MacIntyre, R L Hoover, M Smith, et al.
Indian Journal of Experimental Biology|December 1, 1996
Pharmacological actions of Pongamia pinnata seeds--a preliminary studyR K Singh, V K Joshi, R K Goel, et al.
Indian Journal of Experimental Biology|October 24, 2007
Effect of ethanolic extract of root of Pongamia pinnata (L) pierre on oxidative stress, behavioral and histopathological alterations induced by cerebral ischemia--reperfusion and long-term hypoperfusion in ratsM Raghavendra, Anshuman Trigunayat, R K Singh, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 2, 2003
Effect of Azadirachta indica on paracetamol-induced hepatic damage in albino ratsS U Yanpallewar, S Sen, S Tapas, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 1998
Beta-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the beta-3 adrenergic receptorD S Fletcher, M R Candelore, D Grujic, et al.
The Journal of Experimental Medicine|December 1, 1993
Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8R Meurer, G Van Riper, W Feeney, et al.
Neuroscience|September 18, 2007
Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responsesJ Menetski, S Mistry, M Lu, et al.
Journal of Medicinal Chemistry|May 1, 1989
2,3-Dihydro-5-benzofuranols as antioxidant-based inhibitors of leukotriene biosynthesisM L Hammond, I E Kopka, R A Zambias, et al.
Pharmacological Research|June 22, 1999
Effect of fluoxetine on maximal electroshock seizures in mice: acute vs chronic administrationS S Raju, A R Noor, S Gurthu, et al.
Molecular Pharmacology|July 1, 1991
5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitorsJ F Evans, C Lévillé, J A Mancini, et al.
Pageof 10